These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1343523)
1. [Study of 100 patients treated with iproniazid or "the myth of MAO inhibitors"]. Planche R; Planche F; Planche-Fourthin I; Charbonnier JF; Chassaing JL Ann Med Psychol (Paris); 1992; 150(2-3):220-3; discussion 223-4. PubMed ID: 1343523 [No Abstract] [Full Text] [Related]
2. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia. Sheehan DV Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580 [TBL] [Abstract][Full Text] [Related]
3. [Plea for monoamine oxidase inhibitors. Retrospective study of 350 cases]. Aimard G; Garde A; Henry E; Sevez JF Presse Med; 1984 Apr; 13(16):979-82. PubMed ID: 6232525 [TBL] [Abstract][Full Text] [Related]
4. Refractory depression treated with high doses of monoamine oxidase inhibitor. Guze BH; Baxter LR; Rego J J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984 [TBL] [Abstract][Full Text] [Related]
5. Which antidepressant? Benaim S Br J Clin Pract; 1990 May; 44(5):196-200. PubMed ID: 2390444 [No Abstract] [Full Text] [Related]
6. A clinical overview of monoamine oxidase inhibitors. Zisook S Psychosomatics; 1985 Mar; 26(3):240-6, 251. PubMed ID: 3887453 [No Abstract] [Full Text] [Related]
7. Studies of selective and reversible monoamine oxidase inhibitors. Mann JJ; Aarons SF; Frances AJ; Brown RD J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130 [TBL] [Abstract][Full Text] [Related]
9. A neglected modality in psychiatric treatment--the monoamine oxidase inhibitors. Johnson WC Dis Nerv Syst; 1975 Sep; 36(9):521-5. PubMed ID: 1175468 [TBL] [Abstract][Full Text] [Related]
10. [Indications for therapy using MAO inhibitors]. Schmauss M; Erfurth A Psychiatr Prax; 1989 Aug; 16 Suppl 1():2-6. PubMed ID: 2685853 [TBL] [Abstract][Full Text] [Related]
11. The managment of severe agoraphobia: a comparison of iproniazid and systematic desensitization. Lipsedge MS; Hajioff J; Huggins P; Napier L; Pearce J; Pike DJ; Rich M Psychopharmacologia; 1973 Aug; 32(1):67-80. PubMed ID: 4743236 [No Abstract] [Full Text] [Related]
12. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. Nolen WA Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774 [TBL] [Abstract][Full Text] [Related]
13. Rapid conversion from one monoamine oxidase inhibitor to another. Szuba MP; Hornig-Rohan M; Amsterdam JD J Clin Psychiatry; 1997 Jul; 58(7):307-10. PubMed ID: 9269251 [TBL] [Abstract][Full Text] [Related]
14. Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification. Sheehan DV J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):29-36. PubMed ID: 6429129 [TBL] [Abstract][Full Text] [Related]
15. Differential response patterns to MAO inhibitors and tricyclics. Nies A J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487 [TBL] [Abstract][Full Text] [Related]
17. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature]. Erfurth A; Schmauss M Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650 [TBL] [Abstract][Full Text] [Related]
18. An open multicenter study of the efficacy of MDL 72,974A, a monoamine oxidase type B (MAO-B) inhibitor, in Parkinson's disease. Myllylä VV; Sotaniemi KA; Aasly J; Sjaastad O; Rinne U; McIntyre T; Cremer G Adv Neurol; 1993; 60():676-80. PubMed ID: 8420209 [No Abstract] [Full Text] [Related]
19. Social phobia: long-term treatment outcome and prediction of response--a moclobemide study. Versiani M; Amrein R; Montgomery SA Int Clin Psychopharmacol; 1997 Sep; 12(5):239-54. PubMed ID: 9466158 [TBL] [Abstract][Full Text] [Related]